Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Income Tax Expense
Income taxes recognized for the period, including current and deferred tax.
Income Tax Expense history
Currency unavailable · from the income statement
No Income Tax Expense data reported for this period type.
Income Tax Expense vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $6.21M USD | +39.9% | +53.7% | 0.5% | |
| LTM Mar 2026 | $3.03M USD | -17.4% | -3.7% | 2.6% | |
VCREVicore Pharma Holding AB | LTM Jun 2026 | SEK 103.84K SEK | +264.2% | — | 7.8% |
| LTM Mar 2026 | -$4.66M USD | -249.2% | — | 1.3% | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | +11.2% | +25.0% | 1.9% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.